ROTHFUSS CRISTIN (EVP, General Counsel) received a stock award from SAREPTA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/29/2024ACC: 0000950170-24-131938
Officer· EVP, General Counsel
Since Mar 2026
+6K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
6K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2K
Price / share
—
Trade value
—
% of position
16.9%
11/26/2024
11.82K→13.82K
Total
Net shares
+2K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/26/2024 | A · Award | +2K | — | — | 16.9% | 11.82K | 13.82K |
| Total | +2K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
4K shares
Shares
+4K
Strike price
130.5
Held after
4K
Exercisable
—
11/26/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock4K shares | 11/26/2024 | A · Award | +4K | 130.5 | — | 4K |